<DOC>
	<DOCNO>NCT01376700</DOCNO>
	<brief_summary>The purpose study ass once-weekly prophylactic regimen 25 IU/kg ADVATE start 1 year age onset severe bleed phenotype ( ie , joint bleeding ) , together minimization immunological danger signal , reduce incidence rate inhibitor formation PUPs severe moderately severe hemophilia A .</brief_summary>
	<brief_title>Early Prophylaxis Immunologic Challenge ( EPIC ) Study</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Participants severe moderately severe hemophilia A ( FVIII ≤ 2 % ) Participants &lt; 1 year age Participants must ≤ 3 exposure day ( EDs ) FVIII concentrate FVIIIcontaining product use treatment minor bleeds ( bleeds require 2 infusion per event ) , preventative precautionary infusion follow possible injury Participants prior circumcision allow enroll bleed issue relate circumcision cause original diagnosis hemophilia A 2 EDs FVIII treatment require Adequate venous access ( without need central venous access device ( CVAD ) placement ) determine physician Written inform consent legally authorize representative ( ) Lifethreatening condition ( intracranial hemorrhage , severe trauma ) requirement surgery time enrollment Evidence inhibitor ≥ 0.6 Bethesda Unit ( BU ) Nijmegenmodified Bethesda Assay study start ( sample may retested use lupusinsensitive inhibitor test reduce number false positive inhibitor test result ) Inherited acquire hemostatic defect hemophilia A Any clinically significant , chronic disease hemophilia A Known hypersensitivity ADVATE constituent Any plan elective surgery postpone first 20 EDs Participation Hemophilia Inhibitor Previously Untreated Patient Study Application red blood cell , platelet , leukocyte concentrate , plasma Administration medication affect coagulation platelet function Systemic administration immunomodulatory drug ( eg , chemotherapy , intravenous glucocorticoid ) Participation another clinical study involve investigational product ( IP ) device within 30 day prior study enrollment course study</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>